Tamiflu Capsule
Product Images NDC 0004-0802

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tamiflu (NDC 0004-0802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tamiflu 01)

Chemical Structure (Tamiflu 01)
Chemical structure diagram of the active ingredient in Tamiflu, showing its molecular components and bonding, including an ethoxy group, amide, and phosphate salt form.*
FDA Label Image

Principal Display Panel (30 mg Capsule Blister Pack Carton)

Principal Display Panel (30 mg Capsule Blister Pack Carton)
Tamiflu 30 mg capsules label shows the oseltamivir phosphate active ingredient in a 30 mg strength. The label indicates a package size of 10 capsules and includes the labeler name Genentech, Inc. The label features the National Drug Code (NDC) 0004-0802-85.*
FDA Label Image

Principal Display Panel (45 mg Capsule Blister Pack Carton)

Principal Display Panel (45 mg Capsule Blister Pack Carton)
Tamiflu 45 mg capsules packaging label showing oseltamivir phosphate as the active ingredient. The label indicates a quantity of 10 capsules per package and is labeled by Genentech, Inc. The National Drug Code (NDC) number 0004-0801-85 is visible on the label.*
FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack Carton)

Principal Display Panel (75 mg Capsule Blister Pack Carton)
Tamiflu (oseltamivir phosphate) Capsules 75 mg label shows a partial carton with dosage strength and quantity. It states each capsule contains oseltamivir phosphate equivalent to 75 mg oseltamivir free base. The package contains 10 capsules and is labeled by Genentech, Inc.*
FDA Label Image

Principal Display Panel (60 mL Bottle Carton)

Principal Display Panel (60 mL Bottle Carton)
Tamiflu (oseltamivir phosphate) oral suspension label showing 6 mg/mL strength. The label states each mL contains 6 mg oseltamivir base after constitution, with a total usable volume of 60 mL. It is marked Rx only and displays the Genentech logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.